2011 - CTS-IXA


Parallel Session 8- Immunology (Immunoisolation) (Cell Track)

14.199 - High resolution, non-invasive longitudinal live imaging of immune responses

Presenter: Midhat H, Abdulreda, Miami, United States
Authors: Midhat H. Abdulreda1, Gaetano Faleo1, R. Damaris Molano1, Maite Lopez-Cabezas1, Judith Molina1, Yaohong Tan3, Oscar Ron Echeverria1, Elsie Zahr-Akrawi1, Rayner Rodriguez-Diaz1, Patrick Edlund2, Ingo Leibiger2, Allison Bayer1, Victor Perez3, Camillo Ricordi1,2, Alejandro Caicedo1, Antonello Pileggi1, Per-Olof Berggren1,2


199

High resolution, non-invasive longitudinal live imaging of immune responses

Midhat H. Abdulreda1, Gaetano Faleo1, R. Damaris Molano1, Maite Lopez-Cabezas1, Judith Molina1, Yaohong Tan3, Oscar Ron Echeverria1, Elsie Zahr-Akrawi1, Rayner Rodriguez-Diaz1, Patrick Edlund2, Ingo Leibiger2, Allison Bayer1, Victor Perez3, Camillo Ricordi1,2, Alejandro Caicedo1, Antonello Pileggi1, Per-Olof Berggren1,2

1Diabetes Research Institute, University of Miami, Miami, FL, United States; 2Rolf Luft Center for Diabetes Research and Endocrinology, Karolinska Institutet, Stockholm, Sweden; 3Bascom Palmer Eye Institute, University of Miami, Miami, FL, United States

 

In vivo imaging has emerged as an indispensible tool in biological research. Intravital studies have revealed the significance of immune cell dynamics in the lymph nodes during immune responses. However, little is currently known about the in vivo behavior of T-lymphocytes in peripheral organs, including grafted tissues such as pancreatic islets. This has been primarily due to the combination of the limited noninvasive access to the same tissue in the living animal longitudinally and the relatively low spatial resolution of existing intravital imaging modalities. Here, we noninvasively studied the in vivo movement dynamics of T-lymphocytes that infiltrate pancreatic islets after transplantation. MHC-mismatched DBA/2 mouse islets were transplanted without immunosuppression into the anterior chamber of the eye (ACE) of C57BL/6(B6.129P2-Cxcr6tm1Litt/J) recipients expressing GFP in effector and memory T-lymphocytes. Rejection was characterized by progressive accumulation of GFP-positive lymphocytes paralleled by loss of volume and function of allogeneic islets in the ACE. In vivo analysis of morphology and dynamic behavior of islet-infiltrating effector T-lymphocytes revealed a “ruffled” phenotype of cytotoxic T-lymphocytes that predominated during the effector phase of rejection. Ruffled cells engaged in contacts with other surrounding T-lymphocytes and target islet cells simultaneously. The ruffled phenotype was characterized by a significantly increased but constrained dynamic behavior within the islet allografts. In summary, our results demonstrate that intraocular transplantation enables: (1) longitudinal, non-invasive monitoring of transplanted tissuesin vivo; (2)in vivo cytolabeling to assess cellular phenotype and viabilityin situ; (3) local intervention by topical application or intraocular injection; and (4) real-time tracking of infiltrating immune cells in the target tissue.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi